Feasibility Study of Intra-Tumoral Lipopolysaccharide Immunotherapy for Intra-Abdominal Tumors
Clinical trial NCT05751837 · COMPLETED
Trial details
- NCT number
- NCT05751837
- Sponsor
- Patrick Wagner, MD, FACS
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2023-03-16
- Primary completion
- 2024-05-30
- Enrollment
- 12
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.